I-Mab Catalyst Calendar
Proactively evaluate I-Mab’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of I-Mab Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 24 Nov 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Sep 2020 | Phase I/II Trial Results | AbbVie Inc; I-Mab; Merck & Co Inc; Tianjing Biotechnology (Shanghai) Co Ltd | ABBV; IMAB; MRK | lemzoparlimab | Oncology | B-Cell Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Follicular Lymphoma; Lymphoma; Marginal Zone B-cell Lymphoma; Non-Hodgkin Lymphoma; Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma; Peritoneal Cancer; Primary Mediastinal B-Cell Lymphoma; Solid Tumor; Transitional Cell Cancer (Urothelial Cell Cancer) | Company Press Release |
| 01 Jul 2020 | Phase I Trial Initiation | I-Mab | IMAB | plonmarlimab | Immunology | Rheumatoid Arthritis | Clinical Trial Registry |
| 15 Apr 2020 | Phase I/II Trial Initiation | I-Mab; Tianjing Biotechnology (Shanghai) Co Ltd | IMAB | lemzoparlimab | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward